LECTEVA levodopa/carbidopa/entacapone 75 mg/18.75 mg/200 mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lecteva levodopa/carbidopa/entacapone 75 mg/18.75 mg/200 mg tablet bottle

teva pharma australia pty ltd - levodopa, quantity: 75 mg; carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose; hyprolose; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; glycerol; iron oxide yellow; polysorbate 80; iron oxide red - lecteva (levodopa/carbidopa/entacapone) is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

LECTEVA levodopa/carbidopa/entacapone 50 mg/12.5 mg/200 mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lecteva levodopa/carbidopa/entacapone 50 mg/12.5 mg/200 mg tablet bottle

teva pharma australia pty ltd - levodopa, quantity: 50 mg; carbidopa monohydrate, quantity: 13.5 mg (equivalent: carbidopa, qty 12.5 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose; hyprolose; povidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; glycerol; iron oxide yellow; polysorbate 80; iron oxide red; iron oxide black - lecteva (levodopa/carbidopa/entacapone) is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

MADOPAR RAPID 62.5 dispersible 62.5mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

madopar rapid 62.5 dispersible 62.5mg tablet bottle

roche products pty ltd - benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg); levodopa, quantity: 50 mg - tablet, dispersible - excipient ingredients: magnesium stearate; pregelatinised maize starch; citric acid; microcrystalline cellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

MADOPAR RAPID 125 Dispersible 125mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

madopar rapid 125 dispersible 125mg tablet bottle

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, dispersible - excipient ingredients: citric acid; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

MADOPAR 125 capsule bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

madopar 125 capsule bottle

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - capsule, hard - excipient ingredients: indigo carmine; purified talc; gelatin; iron oxide red; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

MADOPAR 62.5 capsule bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

madopar 62.5 capsule bottle

roche products pty ltd - levodopa, quantity: 50 mg; benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg) - capsule, hard - excipient ingredients: indigo carmine; iron oxide black; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; povidone; mannitol; gelatin - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Madopar Capsules Hard 200mg/50mg Malta - inglês - Medicines Authority

madopar capsules hard 200mg/50mg

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - levodopa, benserazide hydrochloride - hard capsule - levodopa 200 mg benserazide hydrochloride 50 mg - anti-parkinson drugs

Co-Beneldopa 50mg/12.5mg Capsules Malta - inglês - Medicines Authority

co-beneldopa 50mg/12.5mg capsules

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - levodopa, benserazide hydrochloride - hard capsule - levodopa 50 mg benserazide hydrochloride 12.5 mg - anti-parkinson drugs

Madopar 100mg/25mg Dispersible Tablets Malta - inglês - Medicines Authority

madopar 100mg/25mg dispersible tablets

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - levodopa, benserazide hydrochloride - dispersible tablet - levodopa 100 mg benserazide hydrochloride 25 mg - anti-parkinson drugs

Madopar 200mg/50mg Hard Capsules Malta - inglês - Medicines Authority

madopar 200mg/50mg hard capsules

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - levodopa, benserazide hydrochloride - hard capsule - levodopa 200 mg benserazide hydrochloride 50 mg - anti-parkinson drugs